Literature DB >> 29945223

The effect of the DISC1 Ser704Cys polymorphism on striatal dopamine synthesis capacity: an [18F]-DOPA PET study.

Tarik Dahoun1,2,3, Antonio F Pardiñas4, Mattia Veronese5, Michael A P Bloomfield1,2,6,7,8, Sameer Jauhar1,2,6, Ilaria Bonoldi1,2,6, Sean Froudist-Walsh9, Chiara Nosarti6,10, Carsten Korth11, William Hennah12,13,14, James Walters4, Diana Prata15,16,17, Oliver D Howes1,2,6.   

Abstract

Whilst the role of the Disrupted-in-Schizophrenia 1 (DISC1) gene in the aetiology of major mental illnesses is debated, the characterization of its function lends it credibility as a candidate. A key aspect of this functional characterization is the determination of the role of common non-synonymous polymorphisms on normal variation within these functions. The common allele (A) of the DISC1 single-nucleotide polymorphism (SNP) rs821616 encodes a serine (ser) at the Ser704Cys polymorphism, and has been shown to increase the phosphorylation of extracellular signal-regulated protein Kinases 1 and 2 (ERK1/2) that stimulate the phosphorylation of tyrosine hydroxylase, the rate-limiting enzyme for dopamine biosynthesis. We therefore set out to test the hypothesis that human ser (A) homozygotes would show elevated dopamine synthesis capacity compared with cysteine (cys) homozygotes and heterozygotes (TT and AT) for rs821616. [18F]-DOPA positron emission tomography (PET) was used to index striatal dopamine synthesis capacity as the influx rate constant Kicer in healthy volunteers DISC1 rs821616 ser homozygotes (N = 46) and healthy volunteers DISC1 rs821616 cys homozygotes and heterozygotes (N = 56), matched for age, gender, ethnicity and using three scanners. We found DISC1 rs821616 ser homozygotes exhibited a significantly higher striatal Kicer compared with cys homozygotes and heterozygotes (P = 0.012) explaining 6.4% of the variance (partial η2 = 0.064). Our finding is consistent with its previous association with heightened activation of ERK1/2, which stimulates tyrosine hydroxylase activity for dopamine synthesis. This could be a potential mechanism mediating risk for psychosis, lending further credibility to the fact that DISC1 is of functional interest in the aetiology of major mental illness.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29945223      PMCID: PMC6168972          DOI: 10.1093/hmg/ddy242

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  96 in total

1.  Oligomer assembly of the C-terminal DISC1 domain (640-854) is controlled by self-association motifs and disease-associated polymorphism S704C.

Authors:  S Rutger Leliveld; Philipp Hendriks; Max Michel; Gustavo Sajnani; Verian Bader; Svenja Trossbach; Ingrid Prikulis; Rudolf Hartmann; Esther Jonas; Dieter Willbold; Jesús R Requena; Carsten Korth
Journal:  Biochemistry       Date:  2009-08-18       Impact factor: 3.162

2.  Association analysis of the DISC1 gene with schizophrenia in the Japanese population and DISC1 immunoreactivity in the postmortem brain.

Authors:  Woraphat Ratta-Apha; Akitoyo Hishimoto; Kentaro Mouri; Kyoichi Shiroiwa; Toru Sasada; Masakuni Yoshida; Irwan Supriyanto; Yasuhiro Ueno; Migiwa Asano; Osamu Shirakawa; Hideru Togashi; Yoshimi Takai; Ichiro Sora
Journal:  Neurosci Res       Date:  2013-09-04       Impact factor: 3.304

3.  DISC1-NDEL1/NUDEL protein interaction, an essential component for neurite outgrowth, is modulated by genetic variations of DISC1.

Authors:  Atsushi Kamiya; Toshifumi Tomoda; Jennifer Chang; Manabu Takaki; Caixin Zhan; Masahiko Morita; Matthew B Cascio; Sarah Elashvili; Hiroyuki Koizumi; Yasukazu Takanezawa; Faith Dickerson; Robert Yolken; Hiroyuki Arai; Akira Sawa
Journal:  Hum Mol Genet       Date:  2006-10-11       Impact factor: 6.150

4.  Adolescent stress-induced epigenetic control of dopaminergic neurons via glucocorticoids.

Authors:  Minae Niwa; Hanna Jaaro-Peled; Stephanie Tankou; Saurav Seshadri; Takatoshi Hikida; Yurie Matsumoto; Nicola G Cascella; Shin-ichi Kano; Norio Ozaki; Toshitaka Nabeshima; Akira Sawa
Journal:  Science       Date:  2013-01-18       Impact factor: 47.728

Review 5.  Human brain imaging studies of DISC1 in schizophrenia, bipolar disorder and depression: a systematic review.

Authors:  Barbara J Duff; Karine A N Macritchie; Thomas W J Moorhead; Stephen M Lawrie; Douglas H R Blackwood
Journal:  Schizophr Res       Date:  2013-04-16       Impact factor: 4.939

6.  Alterations of GABAergic and dopaminergic systems in mutant mice with disruption of exons 2 and 3 of the Disc1 gene.

Authors:  Tsuyoshi Nakai; Taku Nagai; Rui Wang; Shinnosuke Yamada; Keisuke Kuroda; Kozo Kaibuchi; Kiyofumi Yamada
Journal:  Neurochem Int       Date:  2014-06-26       Impact factor: 3.921

Review 7.  The Role of Genes, Stress, and Dopamine in the Development of Schizophrenia.

Authors:  Oliver D Howes; Robert McCutcheon; Michael J Owen; Robin M Murray
Journal:  Biol Psychiatry       Date:  2016-08-06       Impact factor: 13.382

Review 8.  DISC1-binding proteins in neural development, signalling and schizophrenia.

Authors:  Nicholas J Bradshaw; David J Porteous
Journal:  Neuropharmacology       Date:  2010-12-31       Impact factor: 5.250

9.  DISC1 Ser704Cys impacts thalamic-prefrontal connectivity.

Authors:  Bing Liu; Lingzhong Fan; Yue Cui; Xiaolong Zhang; Bing Hou; Yonghui Li; Wen Qin; Dawei Wang; Chunshui Yu; Tianzi Jiang
Journal:  Brain Struct Funct       Date:  2013-10-22       Impact factor: 3.270

10.  Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia.

Authors:  Cathryn M Lewis; Douglas F Levinson; Lesley H Wise; Lynn E DeLisi; Richard E Straub; Iiris Hovatta; Nigel M Williams; Sibylle G Schwab; Ann E Pulver; Stephen V Faraone; Linda M Brzustowicz; Charles A Kaufmann; David L Garver; Hugh M D Gurling; Eva Lindholm; Hilary Coon; Hans W Moises; William Byerley; Sarah H Shaw; Andrea Mesen; Robin Sherrington; F Anthony O'Neill; Dermot Walsh; Kenneth S Kendler; Jesper Ekelund; Tiina Paunio; Jouko Lönnqvist; Leena Peltonen; Michael C O'Donovan; Michael J Owen; Dieter B Wildenauer; Wolfgang Maier; Gerald Nestadt; Jean-Louis Blouin; Stylianos E Antonarakis; Bryan J Mowry; Jeremy M Silverman; Raymond R Crowe; C Robert Cloninger; Ming T Tsuang; Dolores Malaspina; Jill M Harkavy-Friedman; Dragan M Svrakic; Anne S Bassett; Jennifer Holcomb; Gursharan Kalsi; Andrew McQuillin; Jon Brynjolfson; Thordur Sigmundsson; Hannes Petursson; Elena Jazin; Tomas Zoëga; Tomas Helgason
Journal:  Am J Hum Genet       Date:  2003-06-11       Impact factor: 11.025

View more
  5 in total

1.  A polygenic score indexing a DRD2-related co-expression network is associated with striatal dopamine function.

Authors:  Enrico D'Ambrosio; Giulio Pergola; Antonio F Pardiñas; Tarik Dahoun; Mattia Veronese; Leonardo Sportelli; Paolo Taurisano; Kira Griffiths; Sameer Jauhar; Maria Rogdaki; Michael A P Bloomfield; Sean Froudist-Walsh; Ilaria Bonoldi; James T R Walters; Giuseppe Blasi; Alessandro Bertolino; Oliver D Howes
Journal:  Sci Rep       Date:  2022-07-23       Impact factor: 4.996

2.  Dopamine and glutamate in schizophrenia: biology, symptoms and treatment.

Authors:  Robert A McCutcheon; John H Krystal; Oliver D Howes
Journal:  World Psychiatry       Date:  2020-02       Impact factor: 49.548

3.  Disrupted-in-schizophrenia 1 functional polymorphisms and D2 /D3 receptor availability: A [11 C]-(+)-PHNO imaging study.

Authors:  Tarik Dahoun; Matthew M Nour; Rick A Adams; Svenja Trossbach; Sang H Lee; Hamel Patel; Charles Curtis; Carsten Korth; Oliver D Howes
Journal:  Genes Brain Behav       Date:  2019-07-05       Impact factor: 3.708

Review 4.  Tobacco smoking and dopaminergic function in humans: a meta-analysis of molecular imaging studies.

Authors:  Abhishekh H Ashok; Yuya Mizuno; Oliver D Howes
Journal:  Psychopharmacology (Berl)       Date:  2019-03-18       Impact factor: 4.530

5.  The effect of a genetic variant at the schizophrenia associated AS3MT/BORCS7 locus on striatal dopamine function: A PET imaging study.

Authors:  Enrico D'Ambrosio; Tarik Dahoun; Antonio F Pardiñas; Mattia Veronese; Michael A P Bloomfield; Sameer Jauhar; Ilaria Bonoldi; Maria Rogdaki; Sean Froudist-Walsh; James T R Walters; Oliver D Howes
Journal:  Psychiatry Res Neuroimaging       Date:  2019-07-19       Impact factor: 2.376

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.